Aclaris Therapeutics (ACRS) Asset Writedowns and Impairment (2019 - 2023)
Aclaris Therapeutics (ACRS) recorded quarterly Asset Writedowns and Impairment of $6.6 million in Q4 2023, up 17468.42% quarter-over-quarter from -$38000.0 in Q4 2019.
Aclaris Therapeutics (ACRS) Asset Writedowns and Impairment (2019 - 2023) Analysis & Trends
Aclaris Therapeutics' Asset Writedowns and Impairment history runs 2 years deep, the most recent figure standing at $6.6 million for Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Aclaris Therapeutics | 580.93 Mn | 580.93 Mn | 1.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 6.60 Mn |
| Dec 31, 2023 | 6.60 Mn |
| Dec 31, 2019 | -38,000.00 |
| Dec 31, 2019 | -38,000.00 |